Toward an improved prediction of human in vivo brain penetration. (Q48852162)

16 February 2018

title

Toward an improved prediction of human in vivo brain penetration. (English)

1 reference

16 February 2018

author

Roger N. Gunn

5

1 reference

16 February 2018

author name string

S G Summerfield

1

1 reference

16 February 2018

A J Lucas

2

1 reference

16 February 2018

R A Porter

3

1 reference

16 February 2018

P Jeffrey

4

1 reference

16 February 2018

K R Read

6

1 reference

16 February 2018

A J Stevens

7

1 reference

16 February 2018

A C Metcalf

8

1 reference

16 February 2018

M C Osuna

9

1 reference

16 February 2018

P J Kilford

10

1 reference

16 February 2018

J Passchier

11

1 reference

16 February 2018

A D Ruffo

12

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 December 2008

1 reference

16 February 2018

published in

Xenobiotica

1 reference

16 February 2018

volume

38

1 reference

16 February 2018

issue

12

1 reference

16 February 2018

page(s)

1518-1535

1 reference

16 February 2018

Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Evaluation of the utility of brain slice methods to study brain penetration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Striatal opioid receptor binding in Parkinson's disease, striatonigral degeneration and Steele-Richardson-Olszewski syndrome, A [11C]diprenorphine PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Quantification in positron emission tomography for research in pharmacology and drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Development of a P-glycoprotein knockout model in rodents to define species differences in its functional effect at the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

The impact of P-glycoprotein on the disposition of drugs targeted for indications of the central nervous system: evaluation using the MDR1A/1B knockout mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Parametric in vivo imaging of benzodiazepine receptor distribution in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

An unusual multiple drug intoxication case involving citalopram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Positron emission tomography compartmental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

On the rate and extent of drug delivery to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Brain sizes, surfaces, and neuronal sizes of the cortex cerebri: a stereological investigation of man and his variability and a comparison with some mammals (primates, whales, marsupials, insectivores, and one elephant)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

The blood-brain barrier/neurovascular unit in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Brain concentrations of phenytoin, phenobarbitone and primidone in epileptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Consensus nomenclature for in vivo imaging of reversibly binding radioligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Prediction of human drug clearance from in vitro and preclinical data using physiologically based and empirical approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Influence of nonspecific brain and plasma binding on CNS exposure: implications for rational drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Use of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo p-glycoprotein efflux ratios.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Pharmacokinetic characterization of amantadine in human brain tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Persistence of haloperidol in human brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Distribution of venlafaxine in three postmortem cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Steady-state brain concentrations of antihistamines in rats: interplay of membrane permeability, P-glycoprotein efflux and plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Post-mortem toxico-kinetics of trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Relationship between exposure and nonspecific binding of thirty-three central nervous system drugs in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Tissue distribution of olanzapine in a postmortem case

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Lamotrigine concentrations in human serum, brain tissue, and tumor tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Carbamazepine and carbamazepine-10, 11-epoxide concentrations in human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Preliminary assessment of extrastriatal dopamine D-2 receptor binding in the rodent and nonhuman primate brains using the high affinity radioligand, 18F-fallypride

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Contribution of carrier-mediated transport systems to the blood-brain barrier as a supporting and protecting interface for the brain; importance for CNS drug discovery and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Trends in the development of new medicines by UK-owned pharmaceutical companies (1964-1980).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

The importance of blood collection site for the determination of basic drugs: a case with fluoxetine and diphenhydramine overdose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Fluoxetine overdose: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Simulation and prediction of in vivo drug metabolism in human populations from in vitro data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Increased drug delivery to the brain by P-glycoprotein inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Quantification of Human Opiate Receptor Concentration and Affinity Using High and Low Specific Activity [11C]Diprenorphine and Positron Emission Tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

SPM analysis of parametric (R)-[11C]PK11195 binding images: plasma input versus reference tissue parametric methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Size and density of glial and neuronal cells within the cerebral neocortex of various insectivorian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

In vitro prediction of brain penetration - a case for free thinking?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Improving the in vitro prediction of in vivo central nervous system penetration: integrating permeability, P-glycoprotein efflux, and free fractions in blood and brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Concentration and distribution of thioridazine and metabolites in schizophrenic post-mortem brain tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Tissue distribution of mirtazapine and desmethylmirtazapine in a case of mirtazapine poisoning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

11C-loperamide and its N-desmethyl radiometabolite are avid substrates for brain permeability-glycoprotein efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

The redistribution of selected psychiatric drugs in post-mortem cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802499459

Blood-brain barrier-specific properties of a human adult brain endothelial cell line

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1096/FJ.04-3458FJE

Identifiers

DOI

10.1080/00498250802499459

1 reference

16 February 2018

PubMed ID

18979396

1 reference

16 February 2018